2,374
Views
13
CrossRef citations to date
0
Altmetric
Report

Discovery and characterization of hydroxylysine in recombinant monoclonal antibodies

, &
Pages 371-378 | Received 04 Sep 2015, Accepted 15 Nov 2015, Published online: 28 Jan 2016

Reference

  • Scott AM, Wolchok, JD, Old LJ. Antibody therapy of cancer. Nat Rev Cancer 2012; 12:278-87; PMID:22437872; http://dx.doi.org/10.1038/nrc3236
  • Beck A, Wurch T, Bailly C, Corvaia N. Strategies and challenges for the next generation of therapeutic antibodies. Nat Rev Immunol 2010; 10:345-52; PMID:20414207; http://dx.doi.org/10.1038/nri2747
  • Andreakos E, Taylor PC, Feldmann M. Monoclonal antibodies in immune and inflammatory diseases. Curr Opin Biotechnol 2002; 13:615-20; PMID:12482523; http://dx.doi.org/10.1016/S0958-1669(02)00355-5
  • Klotz L, Wiendl H. Monoclonal antibodies in neuroinflammatory diseases. Expert Opin Biol Ther 2013; 13:831-46; PMID:23521026; http://dx.doi.org/10.1517/14712598.2013.767329
  • Desoubeaux G, Daguet A, Watier H. Therapeutic antibodies and infectious diseases, Tours, France, November 20-22, 2012. MAbs 2013; 5:626-32; PMID:23883703; http://dx.doi.org/10.4161/mabs.25300
  • Goede V, Fischer K, Busch R, Engelke A, Eichhorst B, Wendtner CM, Chagorova T, de la Serna J, Dilhuydy MS, Illmer T, et al. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. N Engl J Med 2014; 370:1101-10; PMID:24401022; http://dx.doi.org/10.1056/NEJMoa1313984
  • Bargou R, Leo E, Zugmaier G, Klinger M, Goebeler M, Knop S, Noppeney R, Viardot A, Hess G, Schuler M, et al. Tumor regression in cancer patients by very low doses of a T cell-engaging antibody. Science 2008; 321:974-7; PMID:18703743; http://dx.doi.org/10.1126/science.1158545
  • Chari RVJ, Miller ML, Widdison WC. Antibody-drug conjugates: an emerging concept in cancer therapy. Angew Chem Int Ed Engl 2014; 53:3796-827; PMID:24677743; http://dx.doi.org/10.1002/anie.201307628
  • Rosenfeld PJ, Schwartz SD, Blumenkranz MS, Miller JW, Haller JA, Reimann JD, Greene WL, Shams N. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Opthalmology 2005; 112:1048-53; http://dx.doi.org/10.1016/j.ophtha.2005.01.043
  • Harris RJ, Murnane AA, Utter SL, Wagner KL, Cox ET, Polastri GD, Helder JC, Sliwkowski MB. Assessing genetic heterogeneity in production cell lines: Detection by peptide mapping of a low level Tyr to Gln sequence variant in a recombinant antibody. Nat Biotechnol 1993; 11:1293-7; http://dx.doi.org/10.1038/nbt1193-1293
  • Liu H, Gaza-Bulsesco G, Faldu D, Chumsae C, Sun J. Heterogeneity of monoclonal antibodies. J Pharm Sci 2008; 97:2426-47; PMID:17828757; http://dx.doi.org/10.1002/jps.21180
  • Walsh G, Jefferis R. Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol 2006; 24:1241-52; PMID:17033665; http://dx.doi.org/10.1038/nbt1252
  • Jeong KJ, Jang SH, Velmurugan N. Recombinant antibodies: engineering and production in yeast and bacterial hosts. Biotechnol J 2011; 6:16-27; PMID:21170983; http://dx.doi.org/10.1002/biot.201000381
  • Houde D, Kauppinen P, Mhatre R, Lyubarskaya Y. Determination of protein oxidation by mass spectrometry and method transfer to quality control. J Chromatogr A 2006; 1123:189-98; PMID:16716331; http://dx.doi.org/10.1016/j.chroma.2006.04.046
  • Zhang Z. Large-scale identification and quantification of covalent modifications in therapeutic proteins. Anal Chem 2009; 81:8354-64; PMID:19764700; http://dx.doi.org/10.1021/ac901193n
  • Junyan JA, Zhang B, Cheng W, Yang YJ. Methionine, tryptophan, and histidine oxidation in a model protein, PTH: mechanisms and stabilization. J Pharm Sci 2009; 98:4485-500; PMID:19455640; http://dx.doi.org/10.1002/jps.21746
  • Guan ZQ, Yates NA, Bakhtiar R. Detection and characterization of methionine oxidation in peptides by collision-induced dissociation and electron capture dissociation. J Am Soc Mass Spectrom 2003; 14:605-13; PMID:12781462; http://dx.doi.org/10.1016/S1044-0305(03)00201-0
  • March RE. An introduction to quadrupole ion trap mass spectrometry. J Mass Spectrom 1997; 32:351-69; http://dx.doi.org/10.1002/(SICI)1096-9888(199704)32:4%3c351::AID-JMS512%3e3.0.CO;2-Y
  • Wiesner J, Premsler T, Sickmann A. Application of electron transfer dissociation (ETD) for the analysis of posttranslational modifications. Proteomics 2008; 8:4466-83; PMID:18972526; http://dx.doi.org/10.1002/pmic.200800329
  • Syka JEP, Coon JJ, Schroeder MJ, Shabanowitz J, Hunt DF. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc Natl Acad Sci USA 2004; 101:9528-33; PMID:15210983; http://dx.doi.org/10.1073/pnas.0402700101
  • Sricholpech M, Perdivara I, Yokoyama M, Nagaoka H, Terajima M, Tomer KB, Yanauchi M. Lysyl hydroxylase 3-mediated glucosylation in type I collagen. J Biol Chem 2012; 287:22998-3009; PMID:22573318; http://dx.doi.org/10.1074/jbc.M112.343954
  • Siegal RC, Pinnell SR, Martin GR. Cross-linking of collagen and elastin. Properties of lysyl oxidase. Biochemistry 1970; 9:4486-92; PMID:5474144; http://dx.doi.org/10.1021/bi00825a004
  • Andrews PC, Hawke D, Shively JE, Dixon JE. Anglerfish preprosomatostatin II is processed to somatostatin-28 and contains hydroxylysine at residue 23*. J Biol Chem 1984; 259:15021-4; PMID:6150931
  • Molony MS, Wu S-L, Keyt LK, Harris RJ. The Unexpected Presence of Hydroxylysine in Non-Collagenous Proteins. Techn Protein Chem 1995; 6:91-8; http://dx.doi.org/10.1016/S1080-8914(06)80014-1
  • Guo, DC, Mant CT, Taneja AK, Parker JMR, Hodges RSJ. Prediction of peptide retention times in reversed-phase high-performance liquid-chromatography I. Determination of retention coefficients of amino acid residues of model synthetic peptides. J Chromatogr A 1986; 359:499-518; http://dx.doi.org/10.1016/0021-9673(86)80102-9
  • March RE, McMahon AW, Londry FA, Alfred RL, Todd JFJ, Vedel F. Resonance excitation of ions stored in a quadrupole ion trap. Part 1. A Simulation Study. Int J Mass Spectrom Ion Processes 1989; 95:119-56; http://dx.doi.org/10.1016/0168-1176(89)83037-X
  • Wu GY, Pereyra B, Seifter S. Specificity of trypsin and carboxypeptidase-B for hydroxylysine residues in denatured collagens. Biochemistry 1981; 20:4321-4; PMID:7284327; http://dx.doi.org/10.1021/bi00518a013
  • Molony MS, Quan C, Mulkerrin MG, Harris RJ. Hydroxylation of Lys residues reduces their susceptibility to digestion by trypsin and lysyl endopeptidase. Anal Biochem 1998; 258:136-7; PMID:9527859; http://dx.doi.org/10.1006/abio.1997.2513
  • Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general amber force field. J Comput Chem 2004; 25:1157-74; PMID:15116359; http://dx.doi.org/10.1002/jcc.20035
  • Risteli M, Niemitalo O, Lankinen H, Juffer AH, Myllyla R. Characterization of collagenous peptides bound to lysyl hydroxylase isoforms. J Biol Chem 2004; 279:37535-43; PMID:15208310; http://dx.doi.org/10.1074/jbc.M405638200
  • Perdivara I, Perera L, Sricholpech M, Terajima M, Pleshko N, Yamauchi M, Tomer KB. Unusual fragmentation pathways in collagen glycopeptides. J Am Soc Mass Spectrom 2013; 24:1072-81; PMID:23633013; http://dx.doi.org/10.1007/s13361-013-0624-y

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.